ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome.Obstet Gynecol. 2018 Jun; 131(6):e157-e171.OG
Abstract
Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Its etiology remains unknown, and treatment is largely symptom based and empirical. PCOS has the potential to cause substantial metabolic sequelae, including an increased risk of diabetes and cardiovascular disease, and these factors should be considered when determining long-term treatment. The purpose of this document is to examine the best available evidence for the diagnosis and clinical management of PCOS.
Links
MeSH
Pub Type(s)
Journal Article
Practice Guideline
Language
eng
PubMed ID
29794677
Clinical Trial Links
Citation
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. "ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome." Obstetrics and Gynecology, vol. 131, no. 6, 2018, pp. e157-e171.
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstet Gynecol. 2018;131(6):e157-e171.
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. (2018). ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstetrics and Gynecology, 131(6), e157-e171. https://doi.org/10.1097/AOG.0000000000002656
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstet Gynecol. 2018;131(6):e157-e171. PubMed PMID: 29794677.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome.
A1 - ,,
PY - 2018/5/26/entrez
PY - 2018/5/26/pubmed
PY - 2019/9/24/medline
SP - e157
EP - e171
JF - Obstetrics and gynecology
JO - Obstet Gynecol
VL - 131
IS - 6
N2 - Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Its etiology remains unknown, and treatment is largely symptom based and empirical. PCOS has the potential to cause substantial metabolic sequelae, including an increased risk of diabetes and cardiovascular disease, and these factors should be considered when determining long-term treatment. The purpose of this document is to examine the best available evidence for the diagnosis and clinical management of PCOS.
SN - 1873-233X
UR - https://www.unboundmedicine.com/medline/citation/29794677/full_citation
DB - PRIME
DP - Unbound Medicine
ER -
